Inventor · disambiguated record
Amy C. H. Lee
Also filed as: LEE AMY · LEE AMY C · LEE AMY C H
13 granted patents·16 pending applications·808 citations·filing 2005–2024
94Inventor score
Files withARBUTUS BIOPHARMA CORP14PROTIVA BIOTHERAPEUTICS INC9GEISBERT THOMAS W1HEYES JAMES1LEE AMY C H1
Top patents by PatentIndex Score
29 records- 0198US8999950B2Compositions and methods for silencing aldehyde dehydrogenasePROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Apr 7, 2015·102 cites·35 claims
- 0298US8188263B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2009·Granted May 29, 2012·241 cites·28 claims
- 0397US9187748B2Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·93 cites·23 claims
- 0496US9428751B2Compositions and methods for silencing apolipoprotein C-III expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 30, 2016·80 cites·15 claims
- 0596US8236943B2Compositions and methods for silencing apolipoprotein BLEE AMY C H·Filed 2010·Granted Aug 7, 2012·234 cites·26 claims
- 0692US12043833B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 0791US11427823B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Aug 30, 2022·5 cites·16 claims
- 0890US8865675B2Compositions and methods for silencing apolipoprotein BHEYES JAMES·Filed 2011·Granted Oct 21, 2014·12 cites·46 claims
- 0990US8716464B2Compositions and methods for silencing Ebola virus gene expressionGEISBERT THOMAS W·Filed 2010·Granted May 6, 2014·11 cites·20 claims
- 1089US10626393B2Delivering CRISPR therapeutics with lipid nanoparticlesARBUTUS BIOPHARMA CORP·Filed 2016·Granted Apr 21, 2020·6 cites·15 claims
- 1186US9035039B2Compositions and methods for silencing SMAD4PROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted May 19, 2015·12 cites·37 claims
- 1283US10415037B2Compositions and methods for silencing hepatitis B virus gene expressionARBUTUS BIOPHARMA CORP·Filed 2015·Granted Sep 17, 2019·7 cites·23 claims
- 1382US2025179496A1Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 1476US9023820B2Compositions and methods for silencing apolipoprotein C-III expressionMACDONALD MARCIA·Filed 2010·Granted May 5, 2015·4 cites·12 claims
- 1570US2023212578A1Compositions and methods for treating hypertriglyceridemiaARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 1669US2024050463A1Therapeutic compositions and methods for treating hepatitis bARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 1759US2021047640A1Compositions and methods for treating hypertriglyceridemiaARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1858US2020385721A1Delivering crispr therapeutics with lipid nanoparticlesARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1955US2024052349A1Targeted conjugates comprising modified sirnaARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 2055US2016264971A1Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2151US2006134189A1siRNA silencing of apolipoprotein BPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2251US2022168430A1Therapeutic methods for treating hepatitis bARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 2349US2023218734A1Compositions and methods for preventing, controlling and diagnosing mycobacterial infectionsUNIV SASKATCHEWAN·Filed 2021·Application pending·0 cites
- 2449US2018245077A1Compositions and methods for treating hypertriglyceridemiaPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2548US2011189300A1siRNA SILENCING OF APOLIPOPROTEIN BPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2646US2022265817A1Therapeutic compositions and methods for treating hepatitis bARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 2745US2019282604A1Therapeutic compositions and methods for treating hepatitis bARBUTUS BIOPHARMA CORP·Filed 2017·Application pending·0 cites
- 2840US2018245074A1Treating hepatitis b virus infection using crisprPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2937US2018208932A1Compositions and methods for silencing hepatitis b virus gene expressionARBUTUS BIOPHARMA CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amy C. H. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →